Korean Practice Patterns for Screening PCA(Prostate Cancer)

Korean's Practice Patterns for Screening PCA(Prostate Cancer) According to PSA(Prostate-specific Antigen) Level

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01371513

Acronym

RESPECT

Enrollment

Registered

2011-06-10

Start date

2010-05-31

Completion date

2011-06-30

Last updated

2017-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign Prostatic Hyperplasia, Neoplasms, Prostate, Prostate Cancer

Keywords

Serum prostate specific antigen

Brief summary

This is to investigate Korean urologist's practice patterns for screening prostate cancer according to PSA level.

Detailed description

This is to investigate Korean urologist's practice patterns for screening prostate cancer according to PSA level.

Interventions

OTHERcontinuous screening

practice patterns for screening prostate cancer

Study design

Observational model

OTHER

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

MALE

Age

40 Years to No maximum

Healthy volunteers

Inclusion criteria

* Male with PSA more than 2.5ng/ml from 1 Jan 2008 to 31 Dec 2008

Exclusion criteria

* Age less than 40 at PSA screening * History of drug use which can affect level of PSA within 6months before PSA screening * Subject who participate any other clinical trial

Design outcomes

Primary

Measure	Time frame
Number of subjects with prostate biopsy	1year

Secondary

Measure	Time frame
Number of subjects with prostate cancer	1year

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026